| 摘要 |
PROBLEM TO BE SOLVED: To obtain a therapeutic agent for peritonitis carcinomatosa and/or cancerous ascites. SOLUTION: The objective therapeutic agent for peritonitis carcinomatosa and/or cancerous ascites includes menatrenone. In more details, the peritonitis carcinomatosa and/or cancerous ascites are caused by digestive cancer, ovarian cancer, uterine cancer, breast cancer, lymphoma or mesothelial tumor. This invention further relates to menatrenone-including therapeutic agent for disseminated cancers.
|
